Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

SD-OCT-guided Intravitreal Ranibizumab Treatment in Choroidal Neovascularization Due to Myopia

NCT03409250 is registered in ClinicalTrials.gov with Vista Klinik as lead sponsor.

NCT NCT03409250
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03409250 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
SD-OCT-guided Intravitreal Ranibizumab Treatment in Choroidal Neovascularization Due to Myopia
Lead sponsor
Vista Klinik
Phase
Phase 4
Overall status
Completed
Start date
June 30, 2011
Completion date
July 31, 2014
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

age related macular degeneration, choroidal neovascularization